High purity oritavancin and method of producing same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9649352
APP PUB NO 20160015772A1
SERIAL NO

14801303

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MELINTA THERAPEUTICS LLC389 INTERPACE PARKWAY SUITE 450 PARSIPPANY NJ 07054

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chemburkar, Sanjay R North Chicago, US 37 101
Ding, Min Parsippany, US 81 1031
Knable, Carl M North Chicago, US 3 0
Krishna, Gopal Parsippany, US 45 455
Petzel, James P North Chicago, US 3 0
Pruyne, Julie J North Chicago, US 8 2
Rafai, Far Adel Mount-Royal, CA 13 27
Reamer, Douglas M North Chicago, US 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00